NeuroGenesis
PrivateLast Round
Grant
Aug 5, 2025
Total Funding Raised
$10M
Company Overview
NeuroGenesis is a clinical-stage cellular therapy company that develops treatments for neurodegenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroGenesis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeuroGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 5, 2025 | ||||
| Series A | Mar 11, 2022 |
Key People
Founding team and executive leadership
NeuroGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Excell Partners | Series A |
| National MS Society | Grant |
| Counterpoint Global (Morgan Stanley) | Series A |
| Rhodium Ventures | Series A |
| New York Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 664% MoM, reaching 1.2K.
NeuroGenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroGenesis's valuation, stock price, and market status.